RECKITT BENCKISER GROUP PLC

SHARE BUYBACK PROGRAMME -

COMPLETION OF FIRST TRANCHE AND COMMENCEMENT OF SECOND TRANCHE

Reckitt Benckiser Group plc ("Reckitt" or the "Company") confirms the successful completion of the first tranche of £250m (the "First Tranche") of its £1 billion share buyback programme (the "Programme") announced on 25 October 2023.

Under the First Tranche, between 30 October 2023 and 30 January 2024, the Company has purchased 4,581,991 ordinary shares of 10p each (the "Ordinary Shares") at an average price of £54.5614, and which are now held in treasury.

Further to the announcement on 20 December 2023, the Company confirms that the second tranche of the Programme (the "Second Tranche") to return a further up to £250 million of capital to shareholders, will commence on 1 February 2024 and will end on or before 10 May 2024.  As previously announced, the purpose of the Second Tranche is to reduce the share capital of the Company. The Second Tranche will take place within the limitations of the authority granted to the Board by shareholders at the Company's Annual General Meeting on 3 May 2023. Pursuant to that authority, the maximum number of shares which remain available for purchase under the Second Tranche is 67,008,009.

As previously announced, Reckitt has entered into a non-discretionary agreement with Merrill Lynch International ("MLI") under which it has issued an irrevocable instruction to MLI to manage the Second Tranche of the Programme.  MLI will, acting as riskless principal, purchase Ordinary Shares for an aggregate purchase price of no greater than £250 million and will simultaneously sell such Ordinary Shares on to the Company. To the extent permitted by law, Ordinary Shares purchased under the Second Tranche of the Programme will be held in treasury.

Any further tranches of the Programme, which may be conducted after completion of the Second Tranche, will be announced in due course.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

CONTACT DETAILS:

Contacts

Richard Joyce                                                                 ​+44 (0)7807 418516

Investor Relations

Catheryn O'Rourke                                                         +44 (0) 1753 217 800

General Counsel & Company Secretary

About Reckitt:

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at www.reckitt.com

* Reckitt is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108